Images |
Sources |
Experiment + Assay |
Phenotypes |
Human Diseases |
|
Fig. J
Kreis J et al. (2021)
|
Xla Wt + ctnnb1 MO
NF10-11.5 (in situ hybridization)
|
|
|
|
Fig. 4C
Colozza G and De Robertis EM (2020)
|
Xla Wt + ctnnb1 MO
NF10 (RT-PCR)
|
|
|
|
Fig.2.C
Chen M et al. (2020)
|
Xla Wt + ctnnb1 + animal cap explant
NF10 (RT-PCR)
|
|
|
|
Fig.3.S1.A
Mukherjee S et al. (2020)
|
Xtr Wt + ctnnb1 MO
NF10.5 (immunohistochemistry)
|
|
|
|
Fig.5.Col.5
Mukherjee S et al. (2020)
|
Xtr Wt + ctnnb1 MO
NF10.5 (in situ hybridization)
|
|
|
|
Fig.3.S1.B
Mukherjee S et al. (2020)
|
Xtr Wt + ctnnb1 MO
NF10.5 (in situ hybridization)
|
|
|
|
Fig.3.S1.C
Mukherjee S et al. (2020)
|
Xtr Wt + ctnnb1 MO
NF35/36 (in situ hybridization)
|
|
|
|
Fig 2 B
Tisler M et al. (2017)
|
Xla Wt + ctnnb1 + dnah9 MO
NF22 (in situ hybridization)
|
|
|
|
Fig.3.C
Lin H et al. (2016)
|
WT + ctnnb1
NF10.5 (RT-PCR)
|
|
|
|
fig.6.a, b
Mimoto MS et al. (2015)
|
Xla Wt + ctnnb1
NF35/36 (in situ hybridization)
|
|
|